Todd A. Aguilera, MD, PhD
"Immunologic responses to short course radiotherapy in rectal adenocarcinoma and the impact of CD40 agonist immunotherapy"
at University of Texas Southwestern Medical Center
Sylvan C. Baca, MD, PhD
"Epigenetic drivers of resistance to novel therapies for bladder and kidney cancer"
at Dana-Farber Cancer Institute
Pavan Bachireddy, MD
"Immune evasive circuits that define MRD progression in myelodysplastic syndrome"
at The University of Texas MD Anderson Cancer Center
Collin M. Blakely, MD, PhD
"Mechanisms of incomplete response and primary resistance to the 3rd generation EGFR inhibitor osimertinib in lung cancer"
at University of California, San Francisco
Kelly L. Bolton, MD, PhD
"The use of enasidenib in IDH2-mutated clonal cytopenia of undetermined significance"
at Washington University School of Medicine
Daniel J. Delitto, MD, PhD
"Pathogen sensing in fibroblasts restrains antitumor immunity in pancreatic cancer"
at Stanford University
Alexander C. Huang, MD
"Shared antigen and neoantigen-specific T cells in checkpoint blockade efficacy and toxicity"
at University of Pennsylvania
Andrew L. Ji, MD
"Dissecting spatial crosstalk in squamous cell carcinoma arising in organ transplant recipients"
at Icahn School of Medicine at Mount Sinai
Anusha Kalbasi, MD
"IL13Ra2 Chimeric Antigen Receptor (CAR) T cells for metastatic melanoma"
at Stanford University School of Medicine
Jennifer M. Kalish, MD, PhD
"Epigenetic and genetic mechanisms of cancer in Beckwith-Wiedemann Syndrome"
at Children's Hospital of Philadelphia
Xiuning Le, MD, PhD
"Structure- and lineage-based classification and targeting of resistance in EGFR-mutant NSCLC"
at The University of Texas MD Anderson Cancer Center
Yvonne M. Mowery, MD, PhD
"Evaluating and targeting pathways of treatment resistance in head and neck squamous cell carcinoma"
at University of Pittsburgh
Benjamin A. Nacev, MD, PhD
"Understanding and targeting chromatin reorganization in ATRX deficient sarcomas"
at University of Pittsburgh
David Y. Oh, MD, PhD
"Co-receptors modulating anti-tumor activity of human cytotoxic CD4+ effector cells"
at University of California, San Francisco
Matthew G. Oser, MD, PhD
"Dissecting and therapeutically exploiting synthetic lethality between NOTCH and TRIM28 to drive anti-tumor immunity in SCLC"
at Dana-Farber Cancer Institute
Phillip L. Palmbos, MD, PhD
"Targeting TRIM29 to reverse immune checkpoint inhibitor resistance in bladder cancer"
at University of Michigan
Sangeetha M. Reddy, MD
"Multi-modality approach to enhancing antigen presentation in breast cancers"
at University of Texas Southwestern Medical Center
Kavita Y. Sarin, MD, PhD
"Genetic contributions and novel therapies for individuals with frequent basal cell cancer"
at Stanford University
Fyza Y. Shaikh, MD, PhD
"Defining microbiome stability and longitudinal shifts as biomarkers of tumor response to immune checkpoint inhibitors across multiple malignancies"
at The Johns Hopkins University School of Medicine
Nathan Singh, MD
"Tailored cellular engineering to overcome costimulation-driven CAR T cell dysfunction"
at Washington University
Melody Smith, MD
"Regulatory mechanisms of the intestinal microbiome on chimeric antigen receptor T cells"
at Stanford University
Santosha A. Vardhana, MD, PhD
"Overcoming metabolic suppression of anti-tumor immunity in gastric cancer"
at Memorial Sloan Kettering Cancer Center
Aaron D. Viny, MD
"Epigenetic coupling of DNA methylation and chromatin structure on leukemic transformation and therapeutic response"
at Columbia University
Daniel R. Wahl, MD, PhD
"Targeting metabolic interactions in the glioblastoma microenvironment to overcome therapy resistance"
at University of Michigan
